Graham K. Cooper
2007 - Orexigen Therapeutics
In 2007, Graham K. Cooper earned a total compensation of $893.3K as Chief Financial Officer and Treasurer at Orexigen Therapeutics, a 80% increase compared to previous year.
Compensation breakdown
Bonus | $147,288 |
---|---|
Option Awards | $416,583 |
Salary | $288,177 |
Other | $41,209 |
Total | $893,257 |
Cooper received $416.6K in option awards, accounting for 47% of the total pay in 2007.
Cooper also received $147.3K in bonus, $288.2K in salary and $41.2K in other compensation.
Rankings
In 2007, Graham K. Cooper's compensation ranked 4,432nd out of 8,700 executives tracked by ExecPay. In other words, Cooper earned more than 49.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,432 out of 8,700 | 49th |
Division Manufacturing | 1,605 out of 3,314 | 52nd |
Major group Chemicals And Allied Products | 320 out of 746 | 57th |
Industry group Drugs | 189 out of 546 | 65th |
Industry Pharmaceutical Preparations | 135 out of 364 | 63rd |
Source: SEC filing on April 28, 2010.
Cooper's colleagues
We found four more compensation records of executives who worked with Graham K. Cooper at Orexigen Therapeutics in 2007.
2007
Gary Tollefson
Orexigen Therapeutics
Chief Executive Officer
2007
Eduardo Dunayevich
Orexigen Therapeutics
Chief Medical Officer
2007
Ronald Landbloom
Orexigen Therapeutics
Vice President of Medical and Regulatory Affairs
2007
Anthony McKinney
Orexigen Therapeutics